At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,296 enrolled
Drug / intervention
Patients with Benign Prostate Hyperplasiaother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Non Interventional Post Authorisation Multicenter Study to Evaluate the Disease Control (Benign Prostate Hyperplasia Control) and Quality of Life (QoL) Following the 6-months Combination Treatment With Dutasteride and Tamsulosin. PROSPERITY Group of Studies (I&II).
In Brief
An observational study evaluating Patients with Benign Prostate Hyperplasia for Benign Prostatic Hyperplasia. Completed, enrolled 1,296 participants across 1 site.
Detailed Summary
Investigation of the efficacy and safety of the stable combination of dutasteride and tamsulosin (Dinaplex®) in the Greek population as well as the evaluation of the quality of life of patients with benign prostatic hyperplasia (BPH) in treatment with a stable combination of dutasteride and tamsulosin (Dinaplex®)
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBenign Prostatic Hyperplasia
CountriesGreece
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedApr 2021
Enrollment StartSep 2021
Primary CompletionOct 2022
TodayJul 2026
First PostedApr 5, 2021
Enrollment StartSep 1, 2021
Primary CompletionOct 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 5.2 years ago
Interventions
Patients with Benign Prostate Hyperplasiaother
patients with benign prostatic hyperplasia under fixed dose combΙnation treatment with dutasteride and tamsulosin